3 Signs You Need a New Medicare Part D Plan

Source Motley_fool

Key Points

  • Medicare's open enrollment period is underway through Dec. 7.

  • You may want to switch drug coverage to reap savings.

  • Consider medication cost and pharmacy access when making your choice.

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

Fall is a much-anticipated time of year for many people. But if you're on Medicare, it's important to participate in a major event happening now through Dec. 7 -- Medicare open enrollment.

During annual open enrollment, Medicare participants can make changes to their coverage. That could mean moving from one Medicare Advantage plan to another or switching Part D drug plans. And if any of these signs apply to you, it may be time to dump your current drug plan and sign up for new Part D coverage.

Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »

A person looking at documents

Image source: Getty Images.

1. Your plan's premiums are rising

Part D plan costs aren't uniform. Unlike Medicare Part B, which has a standard monthly premium that applies to most enrollees, the amount you have to pay for Part D hinges on the plan you choose.

If your plan's premiums are increasing in 2027, it's a sign that you should at least look at different options for the new year. Premiums aren't the only cost associated with Part D drug plans. In fact, it's important to not get too hung up on premium costs and focus on total costs instead. But if you know your plan is getting more expensive off the bat, why not look around and see what else is out there?

2. Your prescription costs have gone up

Medicare Part D plans use formularies that group medications into various tiers. And the higher the tier, the higher the copay typically is.

If you have medications being bumped to a higher tier for 2027, you could end up spending much more on them. In that situation, it pays to see if there's a Part D plan that lets you fill your prescriptions for less.

3. Your plan's pharmacy network is changing

It's important to make sure your medications are affordable under your Part D plan. But it's also crucial to make sure you can fill your prescriptions easily.

If your plan's pharmacy network is changing and you'll no longer have access to convenient options, it pays to see if there's another Part D plan for you. You don't want to run into a situation where you're not on top of your medications because the distance to the closest approved pharmacy is too great.

Your medications probably eat up a good chunk of your retirement budget, so it's important to take steps to make them as affordable as possible. Switching to a new Medicare Part D plan could result in lower premiums, cheaper copays, and better pharmacy access. So it's worth looking around between now and Dec. 7 to see if there's a better plan than the one you currently have.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Market News Today Australia: Nasdaq Sinks 2.6%, Gold Slides as AI Stocks Sell OffNasdaq falls 2.6%, gold drops below $4,100 and oil rises as AI spending fears grow. Explore today's Australian outlook for AUD/USD and the ASX 200.
Author  Mitrade Team
17 hours ago
Nasdaq falls 2.6%, gold drops below $4,100 and oil rises as AI spending fears grow. Explore today's Australian outlook for AUD/USD and the ASX 200.
placeholder
Bitcoin Price Erases Two-Day Gains After $85,000 Rejection: Will it Fall to $80,000?The Bitcoin price has erased its two-day gains after a rejection near $85,000. Bitcoin (BTC) slid about 4% to an intraday low of $81,652 on Bybit.On-chain data and price charts now point to $80,000 as
Author  Beincrypto
18 hours ago
The Bitcoin price has erased its two-day gains after a rejection near $85,000. Bitcoin (BTC) slid about 4% to an intraday low of $81,652 on Bybit.On-chain data and price charts now point to $80,000 as
placeholder
Is the XRP Price Heading for a Major Crash? Whale Inflows Hit a 7-Month HighXRP whales sent $112.4 million to Binance, the highest inflow level in seven months, according to crypto analysts. The move signals rising selling pressure from large holders.However, fresh data sugge
Author  Beincrypto
18 hours ago
XRP whales sent $112.4 million to Binance, the highest inflow level in seven months, according to crypto analysts. The move signals rising selling pressure from large holders.However, fresh data sugge
placeholder
Market News Today Australia: Nasdaq Rallies, Gold Rebounds as Meta Earnings BeatNasdaq rises 1.05%, Meta reports strong earnings and gold rebounds. Explore today's Australian market outlook for oil, AUD/USD and the ASX 200.
Author  Mitrade Team
Yesterday 03: 12
Nasdaq rises 1.05%, Meta reports strong earnings and gold rebounds. Explore today's Australian market outlook for oil, AUD/USD and the ASX 200.
placeholder
Is Bitcoin on the Verge of a Deeper Correction? The S&P 500 May Hold the AnswerBitcoin is consolidating near $82,000 to $83,000 after retreating from recent highs above $87,000. A new CryptoQuant analysis warns that the S&P 500 is showing similar weakness.Analysts are split on w
Author  Beincrypto
Yesterday 01: 48
Bitcoin is consolidating near $82,000 to $83,000 after retreating from recent highs above $87,000. A new CryptoQuant analysis warns that the S&P 500 is showing similar weakness.Analysts are split on w
goTop
quote